Arcus Biosciences, Inc.·4

Jun 7, 4:44 PM ET

Ribas Antoni 4

4 · Arcus Biosciences, Inc. · Filed Jun 7, 2021

Insider Transaction Report

Form 4
Period: 2021-06-03
Ribas Antoni
Director
Transactions
  • Award

    Common Stock

    2021-06-03+3,00011,050 total
  • Award

    Stock Option (Right to Buy)

    2021-06-03+14,10014,100 total
    Exercise: $24.79Exp: 2031-06-02Common Stock (14,100 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    8,553
Footnotes (3)
  • [F1]Represents the grant of restricted stock units that vest 100% on the earlier of June 3, 2022 or the next annual meeting of the stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
  • [F2]Includes 3,000 shares of restricted stock units (previously reported) that vested on June 3, 2021.
  • [F3]The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION